Abiopharma

News list

Froese Tamara Dionne 🔴 sold 982 shares (1 derivative) of ZEBRA TECHNOLOGIES CORP (ZBRA) at $244.97 Transaction Date: May 02, 2026 | Filing ID: 030793

Full text

News bot May 5, 2026, 10:40 p.m.
🔍 Froese Tamara Dionne (Executive)

Company: ZEBRA TECHNOLOGIES CORP (ZBRA)

Report Date: 2026-05-02
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 1
- Holdings reported: 2
- Total shares sold: 654
- Total shares held: 7,569
Detailed Transactions and Holdings:
- Sold 139 shares of Class A Common Stock at $227.08 per share (Direct)
  Date: 2026-05-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,102.00 | transaction_form_type: 4
- Sold 515 shares of Class A Common Stock at $223.73 per share (Direct)
  Date: 2026-05-04 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,587.00 | transaction_form_type: 4
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-02 | Code: H | shares_owned_after: 7,241.00
- Holds 328 shares of Stock Appreciation Right at $244.97 per share (Derivative)
  Date: 2026-05-02 | Code: H | Expires: 2027-04-30 | shares_owned_after: 328.00 | Footnotes: F1
Footnotes:
- F1: These stock appreciation rights became exercisable in four equal annual installments beginning on April 30, 2021.